Furthermore, a recent study, investigating the mutation landscapes in HCC, identified PYCR2 and ADH1 as significant prognostic biomarkers that are involved in the metabolic reprogramming of HCC cells [8]. The gene discussed is ADH1A; the disease is hepatocellular carcinoma.